56
Sistema Dexcom G6 • Cómo usar el G6
Apéndice F: Riesgos y ventajas
Referencias
Aleppo, Grazia, Katrina Ruedy, Tonya Riddlesworth, Davida Kruger, Anne Peters,
Irl Hirsch, Richard Bergenstal, Elena Toschi, Andrew Ahmann, Viral Shah, Michael
Rickels, Bruce Bode, Athena Philis-Tsimikas, Rodica Pop-Busui, Henry Rodriguez, Emily
Eyth, Anuj Bhargava, Craig Kollman, y Roy Beck. 2017. "Replace-BG: a randomized
trial comparing continuous glucose monitoring with and without routine blood
glucose monitoring in well-controlled adults with type 1 diabetes." Diabetes Care.
40(4):538-545. doi: 10.2337/dc16-2482.
Beck, Roy, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal,
Stacie Haller, Craig Kollman, Davida Kruger, Janet McGill, William Polonsky,
Elena Roschi, Howard Wolpert, y David Price por el Grupo de estudio DIAMOND.
2017. "Effect of continuous glucose monitoring on glycemic control in adults with
type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial."
JAMA.317(4):371-378. doi:10.1001/jama.2016.19975.
The Diabetes Control and Complications Trial Research Group. September 30,
1993. "The effect of intensive treatment of diabetes on the development and
progression of long-term complications in insulin-dependent diabetes mellitus."
N Engl J Med. 329:977-986.
Lind, Marcus, William Polonsky, Irl Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist,
Erik Schwarz, Arndis Finna Olafsdottir, Anders Frid, Hand Wedel, Elsa Ahlen, Thomas
Nystom, y Jarl Hellman. 2017. "Continuous glucose monitoring vs conventional
therapy for glycemic control in adults with type 1 diabetes treated with multiple
daily insulin injections: the gold randomized clinical trial." JAMA. 317(4):379-387.
doi:10.1001/jama.2016.19976.
Pettus, Jeremy, David Price, y Steven Edelman. 2015. ‘How patients with type 1
diabetes translate continuous glucose monitoring data into diabetes management
decisions." Endocr Pract. 21(6):613-620. doi: 10.4158/EP14520.OR.
Polonsky, William, Danielle Hessler, Katrina Ruedy, Roy Beck, por el Grupo de estudio
DIAMOND. 2017. "The impact of continuous glucose monitoring on markers of quality
of life in adults with type 1 diabetes: further findings from the DIAMOND randomized
clinical trial." Diabetes Care. 40(6):736-741. doi:10.2337/dc17-0133.